Home

Recent Articles from GlobeNewswire

BingEx Limited Announces Second Quarter 2025 Financial Results
BEIJING, Aug. 19, 2025 (GLOBE NEWSWIRE) -- BingEx Limited (the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier service provider in China (branded as “FlashEx”), today announced its unaudited financial results for the second quarter ended June 30, 2025.
By BingEx Limited · Via GlobeNewswire · August 19, 2025
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that further data on efficacy, safety and subgroup analysis from its recent Phase 3 COMPETE trial will be presented in an oral presentation at the European Society for Medical Oncology (ESMO) Congress, held from October 17-21, 2025 in Berlin, Germany. ITM will also host an educational event focused on bringing together emerging healthcare professionals across disciplines to engage in scientific discussions about the multidisciplinary dynamics in the theranostics field.
Digital Science’s 2025 Catalyst Grant seeking innovations to “see the future” with data visualization
Teams working at intersection of science, design and data could win up to £25,000 for new tech ideas
By Digital Science · Via GlobeNewswire · August 19, 2025
Robinson Helicopter Company Offers New Trade-In Program for Current Robinson Helicopter Owners
New Program Provides Robinson Helicopter Owners a Clear Path to Modernize Aircraft and Prioritize Safety
By Robinson Helicopter Company · Via GlobeNewswire · August 19, 2025
Corbion and Kuehnle AgroSystems join forces to develop natural Astaxanthin from algae fermentation
Corbion, the Amsterdam-based global leader in sustainable ingredients, and US-based biotech company Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae.
By Corbion · Via GlobeNewswire · August 19, 2025
Australia and New Zealand Expand SouthPAN Program with Viasat through $252m AUD Award for Additional Satellite Services
Geoscience Australia and Toitū Te Whenua Land Information New Zealand have expanded the agreement with Viasat for the world class satellite-based augmentation system, SouthPAN
By Viasat, Inc. · Via GlobeNewswire · August 19, 2025
Scientists Discuss the Recent CancerVax Breakthrough
The Company's scientific team describes how they successfully disguised cancer cells and tricked immune cells into attacking them and reveals the next phase of their development plan
By CancerVAX, Inc · Via GlobeNewswire · August 19, 2025
2026 Taoxichuan Art Center Residency Open Call
JINGDEZHEN, China, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Taoxichuan Art Center officially launches the 2026 "Migratory Birds Project" international artists residency program, open to domestic and foreign artists (including, but not limited to, pottery, glass, wood art, etc.) who wish to explore the profound ceramic culture of the birthplace of porcelain.
By Taoxichuan Art Center · Via GlobeNewswire · August 19, 2025
GOGL - Golden Ocean and CMB.TECH - Last Day of Trading in Golden Ocean shares
HAMILTON, Bermuda, 19 August 2025 – Reference is made to the stock exchange announcement on 18 August 2025 by Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean") relating to the key dates for completion of the merger between Golden Ocean and CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (the "Merger").
By Golden Ocean Group Limited · Via GlobeNewswire · August 19, 2025
Progress on share buyback programme
Progress on share buyback programme
By ING Group · Via GlobeNewswire · August 19, 2025
Basilea on track with strong 2025 half-year results
Ad hoc announcement pursuant to Art. 53 LR
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.
Sigma Debuts 200mm f/2 Super-Telephoto Sports Lens, Ultra-Wide 12mm f/1.4 Primes; First Look YouTube Video, Preorder and More Info at B&H
Sigma is releasing the 200mm f/2 super-telephoto sports lens, new ultra-wide 12mm f/1.4 for APS-C prime lenses for full-frame mirrorless cameras.
By B&H Photo Video · Via GlobeNewswire · August 19, 2025
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
By argenx SE · Via GlobeNewswire · August 19, 2025
US Beauty Industry Grows in the First Half of 2025, Circana Reports
CHICAGO, IL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- In the first half of 2025, the U.S. prestige beauty market grew by 2% to $16 billion, while sales at mass merchants increased 4% to $34.6 billion, according to Circana, LLC. Below are the key highlights and takeaways across the beauty landscape through the first six months of the year.  
By Circana · Via GlobeNewswire · August 19, 2025
Master Painter Shawn Mackey Debuts New Tropical Art Collection in Florida, California, and Hawaii Galleries
Key West, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Shawn Mackey, a master painter celebrated both locally and abroad, debuts a new body of work in a series of exhibitions spanning Florida, California, and Hawaii’s cultural hubs. Inspired by the atmosphere and vitality of tropical destinations, the collection brings together scenes of marine life, sunsets, and figures at leisure, rendered with a synthesis of historical and contemporary techniques.
By Shawn Mackey Art Inc. · Via GlobeNewswire · August 18, 2025
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce that it entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with R.F. Lafferty & Co., Inc. (the “Agent”), as the sales agent.
By CYTOMED THERAPEUTICS LIMITED · Via GlobeNewswire · August 18, 2025
VOSK Identifies Most-Referenced Artisan Candle Designs in Customer Feedback Review
Fort Lauderdale, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- VOSK, a Fort Lauderdale-based manufacturer of handmade candles, has released details of a curated list of products that have generated the highest volume of customer references and repeated purchases. The company states that the selection reflects patterns identified in purchasing data and unsolicited reviews.
By VOSK · Via GlobeNewswire · August 18, 2025
NCLA Asks Fourth Circuit to Uphold Pres. Trump’s Right to Tell CPSC Commissioners, ‘You’re Fired!’
Mary Boyle, et al. v. Donald J. Trump, in his official capacity as the President of the United States, et al.
By New Civil Liberties Alliance · Via GlobeNewswire · August 18, 2025
MAG Announces Election Deadline for Arrangement with Pan American
All amounts expressed in U.S. dollars unless otherwise indicated.
By MAG Silver Corp. · Via GlobeNewswire · August 18, 2025
PureTech Systems and Clear Align Partner to Deliver Advanced Autonomous Security and Command-and-Control for U.S. Air Force Tactical Security System
By PureTech Systems · Via GlobeNewswire · August 18, 2025
Flow Capital Announces Early Repayment of Investment in a Sleep Wellness Company
TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”), a leading provider of flexible growth capital and alternative debt solutions, is pleased to announce a successful early repayment of principal with prepayment fees, totalling $1.76 million, on its debt investment in a female founder-led B2C company within the sleep wellness sector. 
By Flow Capital Corp. · Via GlobeNewswire · August 18, 2025
TeraWulf Inc. Announces Upsize and Pricing of $850 Million Convertible Notes Offering
EASTON, Md., Aug. 18, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, predominantly zero-carbon digital infrastructure, today announced the upsize and pricing of its offering of $850 million aggregate principal amount of 1.00% Convertible Senior Notes due 2031 (the “Convertible Notes”). The Convertible Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
By TeraWulf Inc. · Via GlobeNewswire · August 18, 2025
CHARTER (CHTR) ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charter Communications, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Charter (CHTR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 18, 2025
Agora, Inc. Reports Second Quarter 2025 Financial Results
SANTA CLARA, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the second quarter ended June 30, 2025.
By Agora, Inc. · Via GlobeNewswire · August 18, 2025
Cohen Circle Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 22, 2025
PHILADELPHIA, PA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cohen Circle Acquisition Corp. II (NASDAQ:CCIIU) (the “Company”) announced today that, commencing August 22, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “CCII” and “CCIIW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “CCIIU.”
Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025. Sarepta is a commercial-stage biopharmaceutical company that focuses on RNA and gene therapies for the treatment of rare diseases. During the class period, Sarepta was engaged in the development of therapies to treat Duchenne muscular dystrophy (“Duchenne”), including ELEVIDYS. ELEVIDYS is a prescription gene therapy intended for a limited category of people with Duchenne.
By Robbins LLP · Via GlobeNewswire · August 18, 2025
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of common stock to the Warren Township Honorary Policemen’s Benevolent Association (P.B.A.) Local 235.
By Tevogen Bio Inc · Via GlobeNewswire · August 18, 2025
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · August 18, 2025
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S.
By Waldencast plc · Via GlobeNewswire · August 18, 2025
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares of common stock to the Opportunity Project, a Millburn, N.J.–based nonprofit dedicated to empowering individuals with brain injuries through its innovative Clubhouse model. Founded in 1993, Opportunity Project has served more than 600 individuals and their families, providing programs that foster independence, self‑esteem, and community reintegration.
By Tevogen Bio Inc · Via GlobeNewswire · August 18, 2025
Faraday Future Reports Financial Results for Second Quarter 2025
LOS ANGELES, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“FF”, “Faraday Future”, or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced its financial results for its second quarter 2025. The Company highlighted several key metrics that underscore both the operational execution and financial position, as well as its significant progress in its FX brand and product development. The Company also provided an update on subsequent events, FX Super One MPV reveal, “EAI + Crypto” Dual-Flywheel & Dual-Bridge Ecosystem Strategy, and its outlook for the remainder of 2025.
By Faraday Future · Via GlobeNewswire · August 18, 2025
Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer
AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”), today announced that it has appointed Nihanth Badugu as Chief Operating Officer (“COO”) of the Company. Mr. Badugu’s appointment is effective as of August 13, 2025.
By Astrotech Corporation · Via GlobeNewswire · August 18, 2025
BROAD ARROW ACHIEVES NUMEROUS WORLD RECORD PRICES AT 2025 MONTEREY JET CENTER AUCTION
AUCTION LED BY MASERATI MC12 STRADALE AT $5.2 MILLION—THE MOST VALUABLE MODERN MASERATI SOLD AT AUCTION | ADDITIONAL RECORDS SET AS MODERN COLLECTIBLES HIGHLIGHT TWO-DAY SALE | VIEW COMPLETE RESULTS AT BROADARROWAUCTIONS.COM
By Broad Arrow Auctions · Via GlobeNewswire · August 18, 2025
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 6,959,013 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 1,491,217 shares of Vor Bio’s common stock to seven newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).        
By Vor Biopharma · Via GlobeNewswire · August 18, 2025
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
WALTHAM, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA® (pemivibart) against the currently dominant and growing XFG variant of SARS-CoV-2. Notably, and consistent with all dominant variants for the past three years, XFG did not generate any meaningful change to the in vitro neutralization activity of pemivibart or VYD2311, the company’s next generation COVID-19 monoclonal antibody (mAb) candidate, as the epitopes targeted by pemivibart and VYD2311 remain structurally intact. PEMGARDA (pemivibart) is authorized by the U.S. Food and Drug Administration (FDA) for pre-exposure prophylaxis of COVID-19 in certain immunocompromised patients.
By Invivyd · Via GlobeNewswire · August 18, 2025
United Fire Group, Inc. announces new board appointment
CEDAR RAPIDS, Iowa, Aug. 18, 2025 (GLOBE NEWSWIRE) -- United Fire Group, Inc. (UFG) (Nasdaq: UFCS) is pleased to announce the appointment of a new independent member to its board of directors, effective August 15, 2025. Gilda L. Spencer has been appointed as a Class A director and will serve on the board’s risk management and compensation and human capital committees. The board believes Spencer’s extensive legal expertise and deep understanding of the insurance industry will provide valuable guidance on regulatory, governance, and risk management matters critical to the company’s long-term success.
By United Fire Group, Inc · Via GlobeNewswire · August 18, 2025
Graphjet to collaborate with Universiti Kebangsaan Malaysia for the development of thermal management material using graphite
New York, United States, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”) has agreed to support and collaborate with Centre for Materials Engineering and Smart Manufacturing (MERCU) of Universiti Kebangsaan Malaysia (UKM) after receiving a letter of intent from UKM for the Consortium of Research Excellence (KKP) 2025 under the Malaysian Ministry of Higher Education to collaborate on utilising graphite and graphene into additive manufacturing technology to develop advance heat sinks.
By Graphjet Technology · Via GlobeNewswire · August 18, 2025
Amaero Releases Appendix 4E and Audited Financial Report and Issues Letter to Shareholders
~ Revenues from Ordinary Activities up 470% and Revenues from Contracts with Customers from Continuing Operations up 722% to A$3.8 Million ~
By Amaero Ltd · Via GlobeNewswire · August 18, 2025
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, and will retire from the board, not standing for reelection at the 2025 Annual Meeting of Stockholders, scheduled for November 19, 2025.
By Resmed, Inc. · Via GlobeNewswire · August 18, 2025
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy
By Iovance Biotherapeutics, Inc. · Via GlobeNewswire · August 18, 2025
TILT Holdings Announces Closing on Sale of Massachusetts Dispensaries to In Good Health
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (Cboe CA:TILT) (OTCID: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today the closing of the sale of two of its Massachusetts dispensaries to In Good Health. The definitive agreement for this transaction was previously announced on February 3, 2025. Simultaneously, with the closing, the parties entered into an amendment adjusting the purchase price to $1.75 million.
By TILT Holdings Inc. · Via GlobeNewswire · August 18, 2025
Nyxoah Reports Second Quarter Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 18, 2025
The RealReal Announces Upcoming Investor Conference Schedule
SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—announced today that it will participate in the following investor conferences:
By The RealReal · Via GlobeNewswire · August 18, 2025
Diginex Announces 7 to 1 Stock-split paid as Bonus Shares
LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX) (the “Company”), today announced that its board of directors approved a seven-for-one forward stock split to be paid in the form of a share bonus. Each shareholder of the Company of record at the close of business on September 5, 2025 will receive 7 bonus ordinary shares for every one ordinary share held on the record date. The Company expects the bonus shares will be distributed on September 8, 2025.
By Diginex Limited · Via GlobeNewswire · August 18, 2025
ARKO Corp. Announces Departure of Chief Financial Officer Robb Giammatteo
RICHMOND, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced that Chief Financial Officer (“CFO”) Robb Giammatteo will depart the Company to pursue a new opportunity outside the convenience store sector.
By ARKO CORP. · Via GlobeNewswire · August 18, 2025
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Kevin Brodbeck, PhD, to the newly established role of Chief Technical Officer (CTO). Dr. Brodbeck brings more than 25 years of experience leading technical operations, quality assurance, chemistry, manufacturing and controls (CMC), and regulatory activities across a wide range of pharmaceutical products at all stages of development and commercialization. The creation of the CTO role and Dr. Brodbeck’s appointment reflect the impending advancement of ORIC’s clinical programs into late-stage development with the potential start of Phase 3 trials for ORIC-944 and enozertinib (ORIC-114) in 2026.
By ORIC Pharmaceuticals · Via GlobeNewswire · August 18, 2025
Snail, Inc. Announces Second Quarter 2025 Conference Call for Tuesday, August 19, 2025 at 4:30 p.m. ET
CULVER CITY, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, will hold a conference call and webcast on Tuesday, August 19, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2025.
By Snail, Inc. · Via GlobeNewswire · August 18, 2025
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on August 11, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).
By Annexon Biosciences · Via GlobeNewswire · August 18, 2025
Cricut to Present at Upcoming Investor Conferences
SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced that members of its management team are scheduled to present at upcoming investor conferences.
By Cricut, Inc. · Via GlobeNewswire · August 18, 2025
First Advantage Releases Fourth Annual Sustainability Impact Report
The 2024 Report Highlights Progress in Environmental, Community, and Governance Priorities Amid Transformational Growth
By First Advantage Corporation · Via GlobeNewswire · August 18, 2025
FloQast Forms Strategic Alliance with Deloitte Australia to Accelerate Financial Transformation
Alliance combines FloQast’s AI-powered automation platform with Deloitte Australia’s professional services expertise to deliver greater value to clients
By FloQast · Via GlobeNewswire · August 18, 2025
Atlas Partners with Google Cloud to Power the Next Generation of AI-Native 3D Game Development
The agentic 3D content creation platform is built on Google Cloud to deliver scalable AI workflows and unlock a new era of game design
By Atlas · Via GlobeNewswire · August 18, 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCO, WKHS, HBI, SPNS on Behalf of Shareholders
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · August 18, 2025
Home Builders Association of Greater Kansas City Launches New Campaign as the Cost of Housing Rises and Homeownership Slips Out of Reach for Young Families
Kansas City, MO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- As the cost of housing rises and regulations continue to mount, the Home Builders Association of Greater Kansas City (KCHBA) has launched a regional public awareness campaign – “Let Builders Build.”
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Soho House & Co Inc. (NYSE – SHCO), Workhorse Group Inc. (Nasdaq - WKHS), HanesBrands Financial Corp. (NYSE - HBI), Sapiens International Corporation N.V. (Nasdaq –
BALA CYNWYD, Pa., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · August 18, 2025
Terra Balcanica Intersects Gold Mineralization Over 72 m and Starts Drill Program At Brezani Target in Bosnia
Vancouver, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA: UB1) is pleased to announce an expansion of the surface gold skarn system at Brezani and the start of the Phase III drill program at its Viogor-Zanik project, Bosnia and Herzegovina.
By Terra Balcanica Resources Corp. · Via GlobeNewswire · August 18, 2025
Southeast Toyota Finance Ranked Highest in Overall Dealer Satisfaction by J.D. Power
Finance Company Recognized for Dealer Satisfaction Among Captive Mass Market Automotive Finance Lenders for Third Year In-A-Row in the J.D. Power 2025 U.S. Dealer Financing Satisfaction Study SM
By Southeast Toyota Finance · Via GlobeNewswire · August 18, 2025
The Association for Frontotemporal Degeneration Joins Lawmakers to Advance Dementia Awareness in California
AFTD joins FTD advocates – including Emma Heming Willis, wife of actor Bruce Willis – in traveling to the California State Capitol today to mark a state resolution recognizing FTD Awareness Week.
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On August 12, 2025, the Company drew $97.0 million under its existing Amended and Restated Credit Agreement (the “Credit Agreement”), bringing the total outstanding balance to $108 million. The proceeds from the draw were used to settle the 2025 Notes that matured on August 15, 2025.
By Mesa Laboratories, Inc. · Via GlobeNewswire · August 18, 2025
SOVRA Sharpens Focus on GovTech Sector with Series of Strategic Updates
Announces CEO Transition, Acquisition of GovTech AI platform Ontopical
By SOVRA · Via GlobeNewswire · August 18, 2025
NusaTrip Incorporated Announces Closing of Initial Public Offering
Jakarta, Indonesia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- NusaTrip Incorporated (“NusaTrip,” “NUTR” or the “Company”), a travel ecosystem with geographical specialization in Southeast Asia and Asia-Pacific, today announced the closing of its previously announced initial public offering of an aggregate 3,750,000 shares of Common Stock (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of $15.0 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses.
By NusaTrip · Via GlobeNewswire · August 18, 2025
Transaction in Own Shares
Transaction in Own Shares   
By Shell plc · Via GlobeNewswire · August 18, 2025
Black Rock Coffee Bar Files Registration Statement for Proposed Initial Public Offering
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, Inc. (“Black Rock Coffee Bar”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Black Rock Coffee Bar, Inc. · Via GlobeNewswire · August 18, 2025
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today its financial results for the second quarter and six-month period ended June 30, 2025.
By Cosmos Health Inc. · Via GlobeNewswire · August 18, 2025
Nationally Recognized Cardiac Surgeon Tapped to Serve as New Chief Executive of the Lee Health Heart Institute
Fort Myers, Florida, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Lee Health is pleased to welcome nationally recognized cardiac surgeon Dr. Daniel O’Hair as the new chief physician executive of the Lee Health Heart Institute. With more than 25 years of experience, Dr. O’Hair is known for his leadership in advancing cardiovascular care, including expertise in robotic and minimally invasive surgery, transcatheter technologies, and building high-performing heart programs.
By Lee Health · Via GlobeNewswire · August 18, 2025
Fogo de Chão Opens First Location in the Philippines
Internationally renowned restaurant from Brazil makes debut in Asia through partnership with Manila-based Bistro Americano Corp.
By Fogo de Chao · Via GlobeNewswire · August 18, 2025
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
By ONWARD Medical NV · Via GlobeNewswire · August 18, 2025
TalkMe Brings a Penguin to Life at Google I/O, Redefining AI Language Learning
AI-native app showcases storytelling power and user stickiness with 1M+ learners
By INSPIRED AI PTE. LTD. · Via GlobeNewswire · August 18, 2025
ACMA Announces Newly Elected National Board Members
Little Rock, AR, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The American Case Management Association (ACMA) is pleased to announce the results of the 2025 National Board of Directors elections. The following distinguished professionals have been elected to serve on ACMA’s National Board. Their terms will begin on January 1, 2026.
UPDATE - iQor Appoints Natalie Beckerman as EVP and Chief Business Officer
Beckerman to Accelerate Cross-Functional Growth and Drive Strategic Initiatives at the Intersection of Strategy, Operations, and Culture
By iQor US Inc. · Via GlobeNewswire · August 18, 2025
Whitsons and The Abbey Group Bring Local Flavor to New England Schools
Pittsfield, VT, Aug. 18, 2025 (GLOBE NEWSWIRE) -- From Vermont’s rolling dairy farms to Massachusetts’ coastal produce markets, a new partnership is reshaping how students across New England experience school meals.
By Whitsons Culinary Group · Via GlobeNewswire · August 18, 2025
Roadzen Addresses Inaccurate Reporting of Analyst Expectations in Q1 FY2026 Results
Recent media reports, originating from an AI-generated article on The Motley Fool and widely syndicated, misstated Roadzen’s analyst expectations as over $21 million in Q1 revenue, implying a revenue miss of more than 50%. Roadzen clarifies that these figures were never issued by its covering analysts, and that its record first quarter — the strongest Q1 in Company history — was in line with its operating plan and market estimates.
By Roadzen Inc. · Via GlobeNewswire · August 18, 2025
LinkedIn Names Howard University as the Nation’s #1 HBCU Based on Alumni Career Success
Washington, D.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- LinkedIn has unveiled its inaugural Top Colleges rankings of higher education institutions in the United States, naming Howard University as the #1 HBCU. According to LinkedIn, the list identifies the schools that “set graduates up for long-term success.” The ranking used LinkedIn data to gauge the career outcomes of alumni through an analysis of job placement rates, senior-level roles, undergraduate internships, and alumni entrepreneurship. LinkedIn also evaluated how quickly a recent alumnus finds a job or enters graduate school after graduating with an undergraduate degree. The company points out that the return on investment in a degree from a top program includes higher earnings and more rapid career progression. 
By Howard University · Via GlobeNewswire · August 18, 2025
SHAREHOLDER ALERT: Berger Montague Reminds Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors of Class Action Lawsuit Deadline
PHILADELPHIA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spectrum” or the “Company”) on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the “Class Period”).
By Berger Montague · Via GlobeNewswire · August 18, 2025